TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
HROW

Harrow Health Inc

Healthcare · Drug Manufacturers - Specialty & Generic

33.10$ -0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Harrow Health Inc (HROW) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 71 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HROW
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
34 36 35 49 49 67 48 64 72 89 44 71 276
10 11 11 13 12 14 16 16 18 18 17 20 74
24 25 24 36 37 53 32 48 54 71 27 50 202
1.4 3.3 2.1 3.1 2.3 4.8 3.0 2.9 3.3 3.3 5.9 8.1 21
21 26 29 32 34 35 41 33 36 43 43 53 176
22 30 31 35 36 40 44 36 39 47 49 61 196
1.7 -4.9 -6.9 1.5 1.3 13 -11 11 15 24 -22 -11 5.7
5.7 5.1 5.4 5.5 5.5 6.4 6.5 6.4 6.0 5.2 5.5 6.3 23
-2.9 -9.7 -14 -5.8 -4.2 6.3 -18 5.0 1.0 10 -28 -17 -33
1.5 -0.5 3.1 0.7 0.0 -0.5 – – – 3.8 0.0 – –
-4.4 -9.1 -14 -6.5 -4.2 6.8 -18 5.0 1.0 6.6 -28 -17 -37
5.8 -1.7 -5.3 2.5 4.3 18 -6.7 16 12 20 -16 -11 4.5

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?